Theses (Ph. D.)--Marshall University, 2006. / Title from document title page. Includes abstract. Document formatted into pages: contains xiii, 138 p. including illustrations. Bibliography: p. 109-121.

Thesis (Ph.D.) - University of Queensland, 2005. / Includes bibliography.

Thesis (M.S.)--University of Wisconsin--La Crosse, 2002. / Includes bibliographical references.

Thesis (M. Med. Sc.)--University of Hong Kong, 2006.

Thesis (M.P.H.)--University of Hong Kong, 2006.

Thesis (Ph. D.)--Western Conservative Baptist Seminary, 1986. / Abstract. Typescript. Includes bibliographical references (leaves 93-101).

No description available.

No description available.

OBJECTIVE: To determine if applying electroacupuncture at ST 36-37 will lower the systolic, diastolic, and mean blood pressures of chronic hypertensive rats. DESIGN: A 12 week study on the effect of electroacupuncture was conducted from September 2014 to December 2014. The total number of rats used in the study was 16 (n=16). The rats were divided into four groups: Electroacupuncture, Sham-EA, Hypertensive control, and Normotensive control. All of the rats, expect for those in the Normotensive group, were housed in the cold room to induce chronic hypertension. After 8 weeks in the cold room, the rats in the Electroacupuncture group received electrical stimulation twice a week for 30 min. Needles were also inserted into the rats in the Sham-EA group, but there was no electric current. The blood pressures of all of the rats were measured once a week for 12 weeks. Lastly, the data was analyzed using SigmaStat to perform One Way ANOVA and T-tests. RESULT: The initial blood pressures between the 4 groups were similar with a difference of less than 5 mmHg. The groups placed in cold rooms showed a significant difference of more than 20 mmHg compared to their initial blood pressures (P≤0.05) at week 7. Finally, the blood pressures of the Sham-EA and Hypertensive control group did not lower at 12 weeks compared to week 7. However, the systolic, mean, and diastolic blood pressures in the EA group lowered with a significant difference of greater than 20 mmHg at week 12 compared to week 7. There was no significant change between the initial and final blood pressures for those in the Normotensive group. CONCLUSION: The data showed that systolic, diastolic, and mean blood pressures in the Electroacupuncture group lowered significantly at week 12 or after 5 weeks of treatment. Thus, we can conclude that electroacupuncture does have a beneficial effect in lowering blood pressure in chronically hypertensive rats.

Hypertension is both a domestic and international health issue – diagnosed in 1 in 3 U.S. adults and classified by the World Health Organization as the number one risk factor for mortality worldwide. It has been established that salt plays a role in the development of hypertension, and that a salt-sensitive phenotype indicates heightened sensitivity to salt consumption. Here, we studied the roles of the afferent renal nerves, which travel from the kidney to the central nervous system, and the sodium-chloride cotransporter in fluid and electrolyte homeostasis and blood pressure regulation. Our laboratory utilized a novel technique of afferent renal nerve ablation on Sprague-Dawley rats to examine the effects of afferent renal nerve mechanoreceptors and chemoreceptors in response to acute sympathoinhibitory challenges. Additionally, salt-sensitive and salt-resistant rats were randomly subjected to chronic normal salt (0.6% NaCl) or high salt (8% NaCl) diets, and examined for levels of norepinephrine and substance-P release. A different group of salt-resistant and salt-sensitive rats were subcutaneously infused with terazosin, a selective -1 adrenoreceptor antagonist, or propranolol, a selective -adrenoreceptor antagonist, and then randomly subjected to normal salt (0.6% NaCl) or high salt (4% NaCl) diets for 21 days. We subsequently examined these rats, and analyzed the effects of high salt intake on blood pressure, sodium-chloride cotransporter activity, and expression of the sodium-chloride cotransporter and its relevant kinases. In response to an acute mechanoreceptor-specific stimulus, Sprague-Dawley rats that underwent afferent renal nerve ablation were unable to modulate blood pressure or natriuresis after regaining consciousness. Chronic high salt (8% NaCl) consumption in salt-sensitive rats resulted in increased levels of plasma norepinephrine, renal norepinephrine, and norepinephrine-evoked Substance-P release. In addition, salt-sensitive rats subjected to a 21-day high salt (4% NaCl) diet exhibited increased blood pressure, elevated sodium-chloride cotransporter activity, and upregulated levels of the sodium-chloride cotransporter and the kinases that regulate it. However, these observed increases in blood pressure, protein activity, and protein expression were abolished in salt-sensitive rats experiencing -1 adrenoreceptor antagonism due to terazosin administration. In conclusion, our findings indicate that mechanoreceptor-driven afferent renal nerve activation is needed to maintain fluid and electrolyte homeostasis and regulate blood pressure in response to acute sympathoinhibitory challenges and chronic high salt intake. In addition, our data demonstrates that the sodium-chloride cotransporter is aberrantly upregulated in salt-sensitive rats through a norepinephrine-1-adrenoreceptor gated pathway, and this this upregulation results in excessive salt reabsorption. Thus, our experiments have generated new data that reveals selective 1-adrenoreceptor antagonism and renal denervation as potential treatment options for hypertensive individuals.